Pomegranate Juice: Is It Good For Prostate Cancer?

Pomegranate Juice: Is It Good For Prostate Cancer?
Brenda Peralta (RD) Writer: - Registered Dietitian, Certified Diabetes Educator
Dr. Chinedu Anthony Anene Reviewer: - PhD, Senior Lecturer in Bioinformatics
Read in: 11 minutes
Updated:

Article Summary

  • Pomegranates are a rich nutritional source of vitamins and minerals and are high in ellagic acid.
  • Research suggests that ellagic acid slows the growth of tumor cells, and binds with cancer molecules to make them inactive.
  • We will discuss the effects of pomegranate on prostate cancer prevention.
Pomegranate juice draws serious attention in the prostate health world, and it’s not hard to see why. Early studies produced striking numbers. But the picture is considerably more complicated than most headlines suggest, and the honest takeaway is this: the early evidence looked promising, the larger trials didn’t hold up, and no clinical body currently recommends pomegranate juice as a treatment for prostate cancer. The American Cancer Society estimates 313,780 new prostate cancer cases in the United States in 2025, with incidence climbing roughly 3% per year since 2014. That’s a real burden, and it explains why men facing a diagnosis, or a rising PSA, look hard at dietary options. This article walks through what the science actually found, where it fell short, and what any of that means for you.

What the Research Shows About Pomegranate Juice and Prostate Cancer

Pomegranate juice doesn’t cure, prevent, or treat prostate cancer. That framing isn’t supported by the current evidence. What the research does show is more complicated: early-phase trials suggested possible PSA-modulating effects, but those signals weren’t confirmed in larger, controlled trials. Understanding why that distinction matters is the whole point. Solid clinical evidence means controlled, randomized trials with a placebo group, in enough people to detect a real effect. Single-arm Phase II trials don’t meet that bar. They’re useful for generating hypotheses; they aren’t proof. One important complication is that prostate cancer often progresses slowly and irregularly. PSA can shift for reasons that have nothing to do with any intervention. Without a placebo control, there’s no way to know whether a change in PSA doubling time reflects the juice or simply the disease’s natural variation.

Laboratory and Animal Studies

In laboratory settings, pomegranate extracts showed genuine activity against prostate cancer cells. A foundational Food Chemistry study found that pomegranate ellagitannin-derived metabolites inhibited prostate cancer cell growth and concentrated in prostate tissue in mice. Polyphenols from pomegranate cut cell proliferation, ramped up apoptosis (programmed cell death), and blocked pathways tied to tumor invasion. But in-vitro results and mouse models don’t translate automatically to humans. The biological conditions are different in important ways, and more on that below.

Human Clinical Trials

The foundational human trial, published in Clinical Cancer Research (AACR), enrolled men with rising PSA following surgery or radiation. After drinking 8 oz of pomegranate juice daily, mean PSA doubling time jumped from 15 months at baseline to 54 months (P < 0.001). That’s an impressive figure, and it drew considerable attention, including a registered clinical trial at ClinicalTrials.gov. A randomized Phase II study from Johns Hopkins added more data: median PSA doubling time lengthened from 11.9 to 18.5 months in 104 men, with 43% of patients exceeding a 100% increase in PSADT. But Phase II trials don’t include a control group. When a review in Prostate Cancer and Prostatic Diseases examined the full body of pomegranate research, it flagged that absence of controls as a major limitation. And when researchers ran a proper placebo-controlled Phase III trial, pomegranate extract didn’t significantly prolong PSA doubling time compared to placebo. Both arms improved, which strongly suggests the placebo response, combined with natural disease fluctuation, accounted for much of what the earlier trials captured. That’s the honest picture. The NCT00060086 registry and subsequent work identified a potential responder subset (men with the MnSOD AA genotype), but that finding needs replication in larger trials before it changes practice.

How Pomegranate Juice May Work Against Prostate Cancer Cells

PSA doubling time (PSADT) is simply the time it takes for a man’s PSA level to double. A shorter PSADT, under 6 months, points toward aggressive disease progression; a longer one may indicate slower growth. That’s why researchers rely on it as a surrogate endpoint in recurrent prostate cancer studies. The clinical dose tested was 8 oz daily, standardized to 570 mg of total polyphenol gallic acid equivalents. Whether commercially available juices deliver that consistently is a real question. Products vary widely in polyphenol content.

Antioxidants and Plant Compounds

Pomegranate contains ellagitannins, the most concentrated polyphenols found in any commonly consumed juice. In a petri dish, these compounds show real activity: inhibiting NF-κB signaling, promoting apoptosis, and blocking tumor cell invasion. A 2025 Scientific Reports study found that pomegranate seed protein isolates reduced PC-3 prostate cancer cell migration by 35 to 51% compared to control. The catch is bioavailability. Ellagitannins aren’t absorbed intact. They’re hydrolyzed in the gut to ellagic acid, then converted by gut bacteria into urolithins, and only some people’s gut microbiomes produce urolithins efficiently. So two men drinking the same juice daily can have very different active-compound exposures. This is a major reason why a Johns Hopkins randomized trial that controlled for this still showed modest average effects. Pomegranate extract may absorb differently than juice, but no trial has confirmed a clinically meaningful advantage in humans. Similar bioavailability challenges affect other plant compounds studied in prostate health, including vitamin D and prostate cancer risk, lycopene’s mechanisms, and quercetin’s anti-proliferative properties.

Effects on PSA Levels

In the Phase II trials, PSA levels stabilized or declined in a meaningful subset of men. In one randomized study, 13% had declining PSA. But PSA is a biomarker, not a direct measure of tumor burden. A stable PSA doesn’t confirm the cancer is controlled, and PSA can fluctuate independently of disease activity. The Phase III placebo-controlled trial remains the most important data point: no significant difference between pomegranate extract and placebo in the full study population.

PSA, Prostate Cancer Monitoring, and What Pomegranate Juice Can’t Do

PSA doubling time is a clinically useful tool for tracking disease progression. Your urologist uses it to help gauge how quickly a recurrence is developing. It’s not, by itself, a treatment target, and pomegranate juice should never substitute for standard monitoring or medical care. UCLA Health reported that pomegranate juice kept PSA stable in some treated patients. That’s worth acknowledging. But stable PSA in a Phase II cohort without controls doesn’t establish that the juice caused that stability. The risk for any man who substitutes pomegranate juice for medical follow-up is real: prostate cancer can progress during delays, and prostate cancer screening combined with active monitoring catches changes that PSA trends alone can miss. So diet, including foods that may influence PSA levels, plays a complementary role to standard care, not a replacement for it. A proteomics study showed pomegranate juice influenced global gene expression in prostate cancer cells, but gene-expression changes in cell models don’t translate directly into patient outcomes. That’s a research tool, not a clinical finding.

Pomegranate Juice vs Other Foods for Prostate Health

Pomegranate juice has one of the more studied profiles of any single food in prostate cancer research, but the clinical evidence for other dietary options is at least as consistent, and in some cases stronger.

Pomegranate Juice vs Cranberry Juice

Cranberry juice has been studied mainly for urinary tract health rather than prostate cancer. Its polyphenol profile differs from pomegranate’s, and there’s no comparable PSA trial data. For prostate cancer specifically, pomegranate has the larger and more rigorous clinical trial record, even if that record ultimately showed limited benefit.

Other Foods Studied for Prostate Support

The 10 best foods for prostate health include several with strong dietary-pattern data. Lycopene from cooked tomatoes has been associated with lower prostate cancer risk in multiple epidemiological studies. Cooking increases lycopene bioavailability significantly. The benefits of lycopene for men are supported by more consistent observational data than pomegranate. Cruciferous vegetables, broccoli, cauliflower, Brussels sprouts, kale, contain sulforaphane, a compound that activates detoxification enzymes and may inhibit tumor cell growth pathways. Some prospective cohort studies link higher cruciferous vegetable intake to lower prostate cancer risk. Green tea contains EGCG and other catechins that interfere with cancer cell signaling. Lab data is strong; green tea’s effects on the prostate include potential modulation of tumor growth pathways. And turmeric’s curcumin content has been studied for anti-inflammatory and anti-proliferative effects in prostate tissue. These foods sit within dietary patterns, like the Mediterranean diet’s association with prostate cancer, that have stronger population-level evidence than any single food in isolation.

Safety, Side Effects, and Interactions to Know

Natural does not mean risk-free. This matters especially for men on prostate cancer treatment. Pomegranate juice is high in natural sugars, roughly 31 grams per 8 oz serving. For men managing weight, blood glucose, or metabolic health alongside a prostate cancer diagnosis, that sugar load is a genuine consideration, and men with elevated blood sugar should factor it into their overall dietary plan the same way they would any other high-sugar fruit juice in a prediabetic diet. Prostate cancer treatments can themselves affect metabolic parameters, so dietary sugar intake is worth raising with your care team. The more pressing concern is drug interactions. Pomegranate juice inhibits CYP3A4, a liver enzyme responsible for metabolizing many prescription drugs, and research on urolithin-based therapeutic applications has explored this pathway. Men on statin medications may experience altered drug levels when consuming pomegranate regularly, potentially raising side effect risk. Blood thinners like warfarin are affected too, pomegranate can increase anticoagulant activity and elevate bleeding risk. CYP3A4-metabolized chemotherapy agents used in advanced prostate cancer carry the same interaction risk. A foundational PubMed study on pomegranate’s chemoprevention mechanisms identified several active pathways, the same pathways that drive these interactions. Meanwhile, the Phase III placebo-controlled trial reported pomegranate extract was generally well tolerated, but the interaction profile of urolithins across drug classes remains an active area of pharmacological study.

Who Should Be Cautious

Men on anticoagulants (warfarin, apixaban, rivaroxaban) should discuss pomegranate consumption with their prescribing physician before starting. The interaction is clinically relevant. Statin users face the same conversation, given CYP3A4 overlap. If you’re on hormone therapy, chemotherapy, or any active prostate cancer medication, drug-food interactions are a real clinical concern, not a theoretical one. And if you have diabetes or prediabetes, the sugar content is worth factoring into your overall dietary plan. “Natural” doesn’t override pharmacology. Beyond the sugar and interaction considerations, the broader pomegranate juice health benefits, including cardiovascular and anti-inflammatory effects, are sometimes cited as reasons to incorporate it into a general wellness routine, though those claims carry their own evidence limitations.

When to Talk to Your Doctor About Pomegranate and Prostate Cancer

Any man with a prostate cancer diagnosis should talk through dietary changes, including adding pomegranate juice, with his oncologist or urologist before starting. That conversation matters most for men on active treatment, in watchful waiting, or actively monitoring PSA. Understanding your prostate cancer survival rates and prognosis puts context around how closely you and your doctor need to track any changes. Men who prefer lower-sugar alternatives to juice can still access pomegranate’s polyphenols through other preparations; pomegranate tea antioxidant compounds are derived from similar plant sources and may suit those managing glucose levels more closely. This article is informational and not a substitute for personalized medical advice. Your situation, your PSA trajectory, your medications, your stage, determines what dietary choices are appropriate for you.

Frequently Asked Questions

Is pomegranate juice safe to drink if you have prostate cancer?

For most men, moderate consumption is unlikely to cause harm. But “safe” depends heavily on your medications and metabolic health. Pomegranate inhibits CYP3A4 enzymes and can interact with blood thinners, statins, and certain chemotherapy agents. Check with your doctor first.

Can you drink pomegranate juice while taking prostate cancer medications?

It depends on the medication. Drugs metabolized through the CYP3A4 pathway are the main concern, and several prostate cancer treatments fall into that category. Your prescribing physician or a clinical pharmacist can confirm whether your specific regimen has a known interaction.

What’s a realistic timeframe to see changes in PSA levels from drinking pomegranate juice?

The Phase II trials ran for several months before PSA doubling time differences became measurable, and even then, the Phase III trial showed those changes weren’t significantly different from placebo. A 2022 study on aerobic exercise combined with pomegranate juice in men with prostate cancer did find changes in tumor-related biomarkers at 8 weeks, but that involved structured exercise alongside the juice, not juice alone. There’s no established clinical timeframe for juice by itself.

Conclusion

Pomegranate juice is genuinely interesting from a research standpoint. The early PSA doubling time data was striking, and the mechanistic case for its polyphenols is real. But the Phase III placebo-controlled trial is the study that matters most, and it showed no significant benefit over placebo in the overall population. For men asking whether pomegranate juice is good for prostate cancer, the honest answer is: it may be a reasonable addition to a prostate-friendly diet, but it’s not a treatment, doesn’t replace monitoring or medical care, and carries real interaction risks depending on your medications. Good prostate cancer prevention strategies are multi-faceted. Diet is one piece, not the whole picture.

This article is for informational purposes only and does not serve as medical advice. The details provided here are not a replacement for, and should never be depended upon as, professional medical advice. Always consult your physician regarding the potential risks and benefits of any treatment.

Dr. Chinedu Anthony Anene

Dr. Chinedu Anthony Anene

PhD, Senior Lecturer in Bioinformatics

Dr. Chinedu Anthony Anene, PhD, is a Senior Lecturer in Bioinformatics at Leeds Beckett University with expertise in cancer genomics, prostate cancer research, and computational biology.

Read More

Our Medical Review Process

At Ben’s Natural Health, we are committed to maintaining the highest standards of accuracy, transparency, and scientific integrity. Every piece of content is carefully developed by medical professionals and undergoes a thorough review every 12 to 24 months. This ensures that our information remains current, reliable, and rooted in credible, evidence-based research. We reference only peer-reviewed studies from reputable medical journals, providing full citations and direct links to enhance trust and confidence. Learn more about our medical review process and research standards.

Our Editorial Guidelines

For over 25 years, Ben’s Natural Health has been a trusted source of scientifically backed, reliable health information. Our editorial guidelines uphold the highest quality and integrity for every article we publish. Each piece is written by qualified experts and undergoes independent quality checks. We prioritize transparency by clearly displaying contributor credentials and biographies at the beginning of every article. Read more about our editorial standards.

Medical Disclaimer

The content on this blog is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. While our articles are authored and reviewed by licensed medical professionals, they may not address your specific health concerns. Always consult a qualified healthcare provider before making any medical decisions.

Article Sources

  1. https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.70028
  2. https://pubs.acs.org/doi/10.1021/jf071303g
  3. https://aacrjournals.org/clincancerres/article/12/13/4018/284703/Phase-II-Study-of-Pomegranate-Juice-for-Men-with
  4. Jonsson Comprehensive Cancer Center. (2004). Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer (NCT00060086). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT00060086
  5. C. J. Paller, X. Ye, P. J. Wozniak, B. K. Gillespie, P. R. Sieber, R. H. Greengold, et al. (2013). A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer. Prostate Cancer and Prostatic Diseases, 16(1), 50-55. https://doi.org/10.1038/pcan.2012.20
  6. Paller, C J, Pantuck, A, & Carducci, M A (2017). A review of pomegranate in prostate cancer. Prostate Cancer and Prostatic Diseases, 20(3), 265-270. https://doi.org/10.1038/pcan.2017.19
  7. Jonsson Comprehensive Cancer Center. (2004). Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer (NCT00060086). ClinicalTrials.gov. https://ichgcp.net/clinical-trials-registry/NCT00060086
  8. Guzmán-Lorite, Miriam, Muñoz-Moreno, Laura, Marina, María Luisa, Carmena, María José, & García, María Concepción (2025). Assessment of the effect of pomegranate seed extracts on prostate cancer through cellular and animal models. Scientific Reports, 15(1), 20379. https://doi.org/10.1038/s41598-025-07910-w
  9. Paller CJ, Ye X, Wozniak PJ, Gillespie BK, Sieber PR, Greengold RH, et al. (2013). A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer. Prostate cancer and prostatic diseases, 16(1), 50-5. https://doi.org/10.1038/pcan.2012.20
  10. Pantuck, A J, Pettaway, C A, Dreicer, R, Corman, J, Katz, A, Ho, A, et al. (2015). A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer. Prostate Cancer and Prostatic Diseases, 18(3), 242-248. https://doi.org/10.1038/pcan.2015.32
  11. Pomegranate Juice Keeps PSA Levels Stable in Men Treated for Prostate Cancer. uclahealth.org. https://www.uclahealth.org/news/release/pomegranate-juice-keeps-psa-levels-stable-men-treated
  12. Lee ST, Wu YL, Chien LH, Chen ST, Tzeng YK, & Wu TF (2012). Proteomic exploration of the impacts of pomegranate fruit juice on the global gene expression of prostate cancer cell. Proteomics, 12(21), 3251-62. https://doi.org/10.1002/pmic.201200084
  13. https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8183282
  14. Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, & Mukhtar H (2005). Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 102(41), 14813-8. https://doi.org/10.1073/pnas.0505870102
  15. A J Pantuck, C A Pettaway, R Dreicer, J Corman, A Katz, A Ho, et al. (2015). A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer. Prostate cancer and prostatic diseases, 18(3), 242-248. https://doi.org/10.1038/pcan.2015.32
  16. https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8648112
  17. https://doaj.org/article/be6a6790c28848f9b3420e5c267ed6a6

Article Update History

Reviewer:

Dr. Chinedu Anthony Anene PhD, Senior Lecturer in Bioinformatics

Created on February 15, 2020

By Brenda Peralta (RD)

Explore More